REASSURING RESULTS: Drugmaker Merck posted a 2 percent increase in third-quarter profit, at $1.7 billion. That’s despite new generic competition slashing sales for top seller Singulair for asthma and allergies. It had generated $5.5 billion a year.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.